COG — Cambridge Cognition Holdings Share News
0.000.00%
Last trade - 00:00- £16.32m
- £16.06m
- £9.40m
Cambridge Cognition - £1.12m Placing & Subscription, TVR & PDMR Dealings
Brief: Cambridge Cognition Holdings Says Ronald Openshaw Assumes Role Of CFO
Cambridge Cognition - Changes to Board and Management
Cambridge Cognition - Interim Results
RCS - Cambridge Cognition - Monument Therapeutics Partnership with FNIH
Brief: Cambridge Cognition Sees Revenue For 2025 Between £9.5 Mln And £10.0 Mln
Cambridge Cognition - Trading update for period ended 30 June 2025
Brief: Cambridge Cognition Says Monument Therapeutics Achieves Positive Phase I Results For Novel Schizophrenia Treatment
RCS - Cambridge Cognition - Monument Therapeutics Success in Phase I Results
Cambridge Cognition - Notice of AGM
Cambridge Cognition - Holding(s) in Company
Brief: Cambridge Cognition Holdings FY Revenue £10.3 Mln
Cambridge Cognition - Preliminary Unaudited Results
Cambridge Cognition - Notice of Results and Investor Presentation
Brief: Cambridge Cognition Secures 1 Mln Stg Contract For Phase 3 Trial
Cambridge Cognition - Contract Win
Cambridge Cognition - Holding(s) in Company
Brief: Cambridge Cognition Says Selected For Two Phase 3 Trials Combining Digital Cognitive And Voice Solutions
Cambridge Cognition - Contract Win